Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Conducting Operational Qualification (OQ) for Machines – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Conducting Operational Qualification (OQ) for Machines – V 2.0

Standard Operating Procedure for Conducting Operational Qualification (OQ) for Machines


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/150/2025
Supersedes SOP/SIM/150/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP outlines the procedure for conducting Operational Qualification (OQ) for machines used in sterile injectable manufacturing. The aim is to verify and document that the equipment functions consistently within its defined

operating parameters and meets GMP requirements.

2. Scope

This SOP applies to all production equipment and machines installed for use in sterile injectable manufacturing, including filling machines, autoclaves, lyophilizers, mixers, and CIP/SIP systems requiring OQ post-installation or after major maintenance.

3. Responsibilities

  • Validation Executive: Preparation and execution of the OQ protocol.
  • Engineering Officer: Technical support during qualification activities.
  • Quality Assurance (QA): Review and approval of protocols, reports, and deviation management.
See also  Sterile Injectable Manufacturing: SOP for Monitoring Filling Room Air Quality - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring that OQ activities are conducted and documented in compliance with regulatory and company standards.

5. Procedure

5.1 Preparation

  1. Initiate OQ planning upon completion of IQ (Installation Qualification).
  2. Draft the OQ protocol using the standard template approved by QA.
  3. Include test parameters, acceptance criteria, test methods, and equipment to be used.
  4. Obtain approval of the protocol by QA, Production, and Engineering heads.

5.2 Operational Tests

  1. Verify operation of key components such as sensors, actuators, PLCs, alarms, and interlocks.
  2. Conduct tests under minimum, nominal, and maximum load conditions where applicable.
  3. Record results of:
    • Start/stop functionality
    • Temperature and pressure setpoints
    • Cycle times
    • Safety alarms and error handling
  4. Document each test result in the OQ test report (Annexure-1).

5.3 Calibration Verification

  1. Verify calibration of all measurement instruments (e.g., temperature sensors, pressure gauges) used during OQ.
  2. Calibration certificates should be valid and traceable to national/international standards.
See also  Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing - V 2.0

5.4 Software and HMI Checks

  1. Verify that HMI displays are functioning correctly and all setpoints are adjustable.
  2. Check audit trail functionality and electronic signature integrity if applicable (21 CFR Part 11 compliance).

5.5 Deviation Handling

  1. Document any deviations observed during OQ in Annexure-2: Deviation Log.
  2. Perform root cause analysis and implement CAPA (Corrective and Preventive Action).
  3. Re-test failed parameters after implementation of corrective measures.

5.6 Approval and Documentation

  1. Compile all raw data, calibration logs, checklists, and reports into the OQ Summary Report (Annexure-3).
  2. QA reviews the report for completeness and compliance.
  3. OQ is considered complete only after final approval by QA Head.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • OQ: Operational Qualification
  • IQ: Installation Qualification
  • PLC: Programmable Logic Controller
  • CAPA: Corrective and Preventive Action

7. Documents

  • Annexure-1: OQ Test Report
  • Annexure-2: Deviation Log
  • Annexure-3: OQ Summary Report
See also  Sterile Injectable Manufacturing: SOP for Verification of Batch Numbers during Packaging - V 2.0

8. References

  • WHO TRS 937 Annex 4 – Guidelines on Validation
  • ICH Q8, Q9, Q10 Guidelines
  • 21 CFR Part 11 – Electronic Records and Electronic Signatures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Validation Executive QA Executive Head QA
Department Engineering Quality Assurance Quality Assurance

11. Annexures

Annexure-1: OQ Test Report

Test Parameter Setpoint Observed Value Status Tested By
Temperature (°C) 121 120.9 Pass Vikram Joshi

Annexure-2: Deviation Log

Date Deviation Root Cause CAPA Closed By
22/06/2025 Alarm delay PLC lag Software patch applied Rajesh Nair

Annexure-3: OQ Summary Report

Machine ID Protocol No. Execution Date Result Approved By
AUTO-CLV-03 OQ-2025-118 21/06/2025 Accepted Priya Kapoor

Revision History

Revision Date Version Description Reason Approved By
01/01/2022 1.0 Initial issue New SOP QA Head
24/06/2025 2.0 Included calibration and deviation handling Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Recording Utility Validation Data – V 2.0
Next Post: No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version